Schizophrenia therapeutics are used as a standard treatment regimen for schizophrenia. It helps in reversing the low levels of dopamine and serotonin, thereby improving the patient's condition.
Scope of the Report:
This report studies the Schizophrenia Therapeutics market status and outlook of Global and major regions, from angles of players, countries, product types and end industries; this report analyzes the top players in global market, and splits the Schizophrenia Therapeutics market by product type and applications/end industries.
The second-generation antipsychotic drugs segment accounted for the majority market shares because these drugs involve less side effects in comparison to their predecessors. The second-generation antipsychotic drugs are also called as atypical antipsychotic drugs. The increased efficacy and reduced side effects of these drugs improves the negative symptoms, decreases extrapyramidal side-effects (EPSE), and normalizes the level of prolactin. The improvement in negative and cognitive symptoms and the reduction in occurrences of EPSE is attributed to their antagonizing action on serotonin or 5-HT2A receptors. This in turn, will boost the segment’s growth throughout the estimated period.
The global Schizophrenia Therapeutics market is valued at xx million USD in 2017 and is expected to reach xx million USD by the end of 2023, growing at a CAGR of xx% between 2017 and 2023.
The Asia-Pacific will occupy for more market share in following years, especially in China, also fast growing India and Southeast Asia regions.
North America, especially The United States, will still play an important role which cannot be ignored. Any changes from United States might affect the development trend of Schizophrenia Therapeutics.
Europe also play important roles in global market, with market size of xx million USD in 2017 and will be xx million USD in 2023, with a CAGR of xx%.
Market Segment by Companies, this report covers
AstraZeneca
Eli Lilly
GlaxoSmithKline
Johnson & Johnson
Alkermes
AbbVie
Amgen
Bristol-Myers Squibb
Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Market Segment by Type, covers
First-Generation Antipsychotic Drugs
Second-Generation Antipsychotic Drugs
Third-Generation Antipsychotic Drugs
Market Segment by Applications, can be divided into
Hospitals
Clinics
Other
Table of Contents
1 Schizophrenia Therapeutics Market Overview
1.1 Product Overview and Scope of Schizophrenia Therapeutics
1.2 Classification of Schizophrenia Therapeutics by Types
1.2.1 Global Schizophrenia Therapeutics Revenue Comparison by Types (2017-2023)
1.2.2 Global Schizophrenia Therapeutics Revenue Market Share by Types in 2017
1.2.3 First-Generation Antipsychotic Drugs
1.2.4 Second-Generation Antipsychotic Drugs
1.2.5 Third-Generation Antipsychotic Drugs
1.3 Global Schizophrenia Therapeutics Market by Application
1.3.1 Global Schizophrenia Therapeutics Market Size and Market Share Comparison by Applications (2013-2023)
1.3.2 Hospitals
1.3.3 Clinics
1.3.4 Other
1.4 Global Schizophrenia Therapeutics Market by Regions
1.4.1 Global Schizophrenia Therapeutics Market Size (Million USD) Comparison by Regions (2013-2023)
1.4.1 North America (USA, Canada and Mexico) Schizophrenia Therapeutics Status and Prospect (2013-2023)
1.4.2 Europe (Germany, France, UK, Russia and Italy) Schizophrenia Therapeutics Status and Prospect (2013-2023)
1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Schizophrenia Therapeutics Status and Prospect (2013-2023)
1.4.4 South America (Brazil, Argentina, Colombia) Schizophrenia Therapeutics Status and Prospect (2013-2023)
1.4.5 Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Schizophrenia Therapeutics Status and Prospect (2013-2023)
1.5 Global Market Size of Schizophrenia Therapeutics (2013-2023)
2 Manufacturers Profiles
2.1 AstraZeneca
2.1.1 Business Overview
2.1.2 Schizophrenia Therapeutics Type and Applications
2.1.2.1 Product A
2.1.2.2 Product B
2.1.3 AstraZeneca Schizophrenia Therapeutics Revenue, Gross Margin and Market Share (2016-2017)
2.2 Eli Lilly
2.2.1 Business Overview
2.2.2 Schizophrenia Therapeutics Type and Applications
2.2.2.1 Product A
2.2.2.2 Product B
2.2.3 Eli Lilly Schizophrenia Therapeutics Revenue, Gross Margin and Market Share (2016-2017)
2.3 GlaxoSmithKline
2.3.1 Business Overview
2.3.2 Schizophrenia Therapeutics Type and Applications
2.3.2.1 Product A
2.3.2.2 Product B
2.3.3 GlaxoSmithKline Schizophrenia Therapeutics Revenue, Gross Margin and Market Share (2016-2017)
2.4 Johnson & Johnson
2.4.1 Business Overview
2.4.2 Schizophrenia Therapeutics Type and Applications
2.4.2.1 Product A
2.4.2.2 Product B
2.4.3 Johnson & Johnson Schizophrenia Therapeutics Revenue, Gross Margin and Market Share (2016-2017)
2.5 Alkermes
2.5.1 Business Overview
2.5.2 Schizophrenia Therapeutics Type and Applications
2.5.2.1 Product A
2.5.2.2 Product B
2.5.3 Alkermes Schizophrenia Therapeutics Revenue, Gross Margin and Market Share (2016-2017)
2.6 AbbVie
2.6.1 Business Overview
2.6.2 Schizophrenia Therapeutics Type and Applications
2.6.2.1 Product A
2.6.2.2 Product B
2.6.3 AbbVie Schizophrenia Therapeutics Revenue, Gross Margin and Market Share (2016-2017)
2.7 Amgen
2.7.1 Business Overview
2.7.2 Schizophrenia Therapeutics Type and Applications
2.7.2.1 Product A
2.7.2.2 Product B
2.7.3 Amgen Schizophrenia Therapeutics Revenue, Gross Margin and Market Share (2016-2017)
2.8 Bristol-Myers Squibb
2.8.1 Business Overview
2.8.2 Schizophrenia Therapeutics Type and Applications
2.8.2.1 Product A
2.8.2.2 Product B
2.8.3 Bristol-Myers Squibb Schizophrenia Therapeutics Revenue, Gross Margin and Market Share (2016-2017)
3 Global Schizophrenia Therapeutics Market Competition, by Players
3.1 Global Schizophrenia Therapeutics Revenue and Share by Players (2013-2018)
3.2 Market Concentration Rate
3.2.1 Top 5 Schizophrenia Therapeutics Players Market Share
3.2.2 Top 10 Schizophrenia Therapeutics Players Market Share
3.3 Market Competition Trend
4 Global Schizophrenia Therapeutics Market Size by Regions
4.1 Global Schizophrenia Therapeutics Revenue and Market Share by Regions
4.2 North America Schizophrenia Therapeutics Revenue and Growth Rate (2013-2018)
4.3 Europe Schizophrenia Therapeutics Revenue and Growth Rate (2013-2018)
4.4 Asia-Pacific Schizophrenia Therapeutics Revenue and Growth Rate (2013-2018)
4.5 South America Schizophrenia Therapeutics Revenue and Growth Rate (2013-2018)
4.6 Middle East and Africa Schizophrenia Therapeutics Revenue and Growth Rate (2013-2018)
5 North America Schizophrenia Therapeutics Revenue by Countries
5.1 North America Schizophrenia Therapeutics Revenue by Countries (2013-2018)
5.2 USA Schizophrenia Therapeutics Revenue and Growth Rate (2013-2018)
5.3 Canada Schizophrenia Therapeutics Revenue and Growth Rate (2013-2018)
5.4 Mexico Schizophrenia Therapeutics Revenue and Growth Rate (2013-2018)
6 Europe Schizophrenia Therapeutics Revenue by Countries
6.1 Europe Schizophrenia Therapeutics Revenue by Countries (2013-2018)
6.2 Germany Schizophrenia Therapeutics Revenue and Growth Rate (2013-2018)
6.3 UK Schizophrenia Therapeutics Revenue and Growth Rate (2013-2018)
6.4 France Schizophrenia Therapeutics Revenue and Growth Rate (2013-2018)
6.5 Russia Schizophrenia Therapeutics Revenue and Growth Rate (2013-2018)
6.6 Italy Schizophrenia Therapeutics Revenue and Growth Rate (2013-2018)
7 Asia-Pacific Schizophrenia Therapeutics Revenue by Countries
7.1 Asia-Pacific Schizophrenia Therapeutics Revenue by Countries (2013-2018)
7.2 China Schizophrenia Therapeutics Revenue and Growth Rate (2013-2018)
7.3 Japan Schizophrenia Therapeutics Revenue and Growth Rate (2013-2018)
7.4 Korea Schizophrenia Therapeutics Revenue and Growth Rate (2013-2018)
7.5 India Schizophrenia Therapeutics Revenue and Growth Rate (2013-2018)
7.6 Southeast Asia Schizophrenia Therapeutics Revenue and Growth Rate (2013-2018)
8 South America Schizophrenia Therapeutics Revenue by Countries
8.1 South America Schizophrenia Therapeutics Revenue by Countries (2013-2018)
8.2 Brazil Schizophrenia Therapeutics Revenue and Growth Rate (2013-2018)
8.3 Argentina Schizophrenia Therapeutics Revenue and Growth Rate (2013-2018)
8.4 Colombia Schizophrenia Therapeutics Revenue and Growth Rate (2013-2018)
9 Middle East and Africa Revenue Schizophrenia Therapeutics by Countries
9.1 Middle East and Africa Schizophrenia Therapeutics Revenue by Countries (2013-2018)
9.2 Saudi Arabia Schizophrenia Therapeutics Revenue and Growth Rate (2013-2018)
9.3 UAE Schizophrenia Therapeutics Revenue and Growth Rate (2013-2018)
9.4 Egypt Schizophrenia Therapeutics Revenue and Growth Rate (2013-2018)
9.5 Nigeria Schizophrenia Therapeutics Revenue and Growth Rate (2013-2018)
9.6 South Africa Schizophrenia Therapeutics Revenue and Growth Rate (2013-2018)
10 Global Schizophrenia Therapeutics Market Segment by Type
10.1 Global Schizophrenia Therapeutics Revenue and Market Share by Type (2013-2018)
10.2 Global Schizophrenia Therapeutics Market Forecast by Type (2018-2023)
10.3 First-Generation Antipsychotic Drugs Revenue Growth Rate (2013-2023)
10.4 Second-Generation Antipsychotic Drugs Revenue Growth Rate (2013-2023)
10.5 Third-Generation Antipsychotic Drugs Revenue Growth Rate (2013-2023)
11 Global Schizophrenia Therapeutics Market Segment by Application
11.1 Global Schizophrenia Therapeutics Revenue Market Share by Application (2013-2018)
11.2 Schizophrenia Therapeutics Market Forecast by Application (2018-2023)
11.3 Hospitals Revenue Growth (2013-2018)
11.4 Clinics Revenue Growth (2013-2018)
11.5 Other Revenue Growth (2013-2018)
12 Global Schizophrenia Therapeutics Market Size Forecast (2018-2023)
12.1 Global Schizophrenia Therapeutics Market Size Forecast (2018-2023)
12.2 Global Schizophrenia Therapeutics Market Forecast by Regions (2018-2023)
12.3 North America Schizophrenia Therapeutics Revenue Market Forecast (2018-2023)
12.4 Europe Schizophrenia Therapeutics Revenue Market Forecast (2018-2023)
12.5 Asia-Pacific Schizophrenia Therapeutics Revenue Market Forecast (2018-2023)
12.6 South America Schizophrenia Therapeutics Revenue Market Forecast (2018-2023)
12.7 Middle East and Africa Schizophrenia Therapeutics Revenue Market Forecast (2018-2023)
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Data Source
List of Tables and Figures
Figure Schizophrenia Therapeutics Picture
Table Product Specifications of Schizophrenia Therapeutics
Table Global Schizophrenia Therapeutics and Revenue (Million USD) Market Split by Product Type
Figure Global Schizophrenia Therapeutics Revenue Market Share by Types in 2017
Figure First-Generation Antipsychotic Drugs Picture
Figure Second-Generation Antipsychotic Drugs Picture
Figure Third-Generation Antipsychotic Drugs Picture
Table Global Schizophrenia Therapeutics Revenue (Million USD) by Application (2013-2023)
Figure Schizophrenia Therapeutics Revenue Market Share by Applications in 2017
Figure Hospitals Picture
Figure Clinics Picture
Figure Other Picture
Table Global Market Schizophrenia Therapeutics Revenue (Million USD) Comparison by Regions 2013-2023
Figure North America Schizophrenia Therapeutics Revenue (Million USD) and Growth Rate (2013-2023)
Figure Europe Schizophrenia Therapeutics Revenue (Million USD) and Growth Rate (2013-2023)
Figure Asia-Pacific Schizophrenia Therapeutics Revenue (Million USD) and Growth Rate (2013-2023)
Figure South America Schizophrenia Therapeutics Revenue (Million USD) and Growth Rate (2013-2023)
Figure Middle East and Africa Schizophrenia Therapeutics Revenue (Million USD) and Growth Rate (2013-2023)
Figure Global Schizophrenia Therapeutics Revenue (Million USD) and Growth Rate (2013-2023)
Table AstraZeneca Basic Information, Manufacturing Base and Competitors
Table AstraZeneca Schizophrenia Therapeutics Type and Applications
Table AstraZeneca Schizophrenia Therapeutics Revenue, Gross Margin and Market Share (2016-2017)
Table Eli Lilly Basic Information, Manufacturing Base and Competitors
Table Eli Lilly Schizophrenia Therapeutics Type and Applications
Table Eli Lilly Schizophrenia Therapeutics Revenue, Gross Margin and Market Share (2016-2017)
Table GlaxoSmithKline Basic Information, Manufacturing Base and Competitors
Table GlaxoSmithKline Schizophrenia Therapeutics Type and Applications
Table GlaxoSmithKline Schizophrenia Therapeutics Revenue, Gross Margin and Market Share (2016-2017)
Table Johnson & Johnson Basic Information, Manufacturing Base and Competitors
Table Johnson & Johnson Schizophrenia Therapeutics Type and Applications
Table Johnson & Johnson Schizophrenia Therapeutics Revenue, Gross Margin and Market Share (2016-2017)
Table Alkermes Basic Information, Manufacturing Base and Competitors
Table Alkermes Schizophrenia Therapeutics Type and Applications
Table Alkermes Schizophrenia Therapeutics Revenue, Gross Margin and Market Share (2016-2017)
Table AbbVie Basic Information, Manufacturing Base and Competitors
Table AbbVie Schizophrenia Therapeutics Type and Applications
Table AbbVie Schizophrenia Therapeutics Revenue, Gross Margin and Market Share (2016-2017)
Table Amgen Basic Information, Manufacturing Base and Competitors
Table Amgen Schizophrenia Therapeutics Type and Applications
Table Amgen Schizophrenia Therapeutics Revenue, Gross Margin and Market Share (2016-2017)
Table Bristol-Myers Squibb Basic Information, Manufacturing Base and Competitors
Table Bristol-Myers Squibb Schizophrenia Therapeutics Type and Applications
Table Bristol-Myers Squibb Schizophrenia Therapeutics Revenue, Gross Margin and Market Share (2016-2017)
Table Global Schizophrenia Therapeutics Revenue (Million USD) by Players (2013-2018)
Table Global Schizophrenia Therapeutics Revenue Share by Players (2013-2018)
Figure Global Schizophrenia Therapeutics Revenue Share by Players in 2016
Figure Global Schizophrenia Therapeutics Revenue Share by Players in 2017
Figure Global Top 5 Players Schizophrenia Therapeutics Revenue Market Share in 2017
Figure Global Top 10 Players Schizophrenia Therapeutics Revenue Market Share in 2017
Figure Global Schizophrenia Therapeutics Revenue (Million USD) and Growth Rate (%) (2013-2018)
Table Global Schizophrenia Therapeutics Revenue (Million USD) by Regions (2013-2018)
Table Global Schizophrenia Therapeutics Revenue Market Share by Regions (2013-2018)
Figure Global Schizophrenia Therapeutics Revenue Market Share by Regions (2013-2018)
Figure Global Schizophrenia Therapeutics Revenue Market Share by Regions in 2017
Figure North America Schizophrenia Therapeutics Revenue and Growth Rate (2013-2018)
Figure Europe Schizophrenia Therapeutics Revenue and Growth Rate (2013-2018)
Figure Asia-Pacific Schizophrenia Therapeutics Revenue and Growth Rate (2013-2018)
Figure South America Schizophrenia Therapeutics Revenue and Growth Rate (2013-2018)
Figure Middle East and Africa Schizophrenia Therapeutics Revenue and Growth Rate (2013-2018)
Table North America Schizophrenia Therapeutics Revenue by Countries (2013-2018)
Table North America Schizophrenia Therapeutics Revenue Market Share by Countries (2013-2018)
Figure North America Schizophrenia Therapeutics Revenue Market Share by Countries (2013-2018)
Figure North America Schizophrenia Therapeutics Revenue Market Share by Countries in 2017
Figure USA Schizophrenia Therapeutics Revenue and Growth Rate (2013-2018)
Figure Canada Schizophrenia Therapeutics Revenue and Growth Rate (2013-2018)
Figure Mexico Schizophrenia Therapeutics Revenue and Growth Rate (2013-2018)
Table Europe Schizophrenia Therapeutics Revenue (Million USD) by Countries (2013-2018)
Figure Europe Schizophrenia Therapeutics Revenue Market Share by Countries (2013-2018)
Figure Europe Schizophrenia Therapeutics Revenue Market Share by Countries in 2017
Figure Germany Schizophrenia Therapeutics Revenue and Growth Rate (2013-2018)
Figure UK Schizophrenia Therapeutics Revenue and Growth Rate (2013-2018)
Figure France Schizophrenia Therapeutics Revenue and Growth Rate (2013-2018)
Figure Russia Schizophrenia Therapeutics Revenue and Growth Rate (2013-2018)
Figure Italy Schizophrenia Therapeutics Revenue and Growth Rate (2013-2018)
Table Asia-Pacific Schizophrenia Therapeutics Revenue (Million USD) by Countries (2013-2018)
Figure Asia-Pacific Schizophrenia Therapeutics Revenue Market Share by Countries (2013-2018)
Figure Asia-Pacific Schizophrenia Therapeutics Revenue Market Share by Countries in 2017
Figure China Schizophrenia Therapeutics Revenue and Growth Rate (2013-2018)
Figure Japan Schizophrenia Therapeutics Revenue and Growth Rate (2013-2018)
Figure Korea Schizophrenia Therapeutics Revenue and Growth Rate (2013-2018)
Figure India Schizophrenia Therapeutics Revenue and Growth Rate (2013-2018)
Figure Southeast Asia Schizophrenia Therapeutics Revenue and Growth Rate (2013-2018)
Table South America Schizophrenia Therapeutics Revenue by Countries (2013-2018)
Table South America Schizophrenia Therapeutics Revenue Market Share by Countries (2013-2018)
Figure South America Schizophrenia Therapeutics Revenue Market Share by Countries (2013-2018)
Figure South America Schizophrenia Therapeutics Revenue Market Share by Countries in 2017
Figure Brazil Schizophrenia Therapeutics Revenue and Growth Rate (2013-2018)
Figure Argentina Schizophrenia Therapeutics Revenue and Growth Rate (2013-2018)
Figure Colombia Schizophrenia Therapeutics Revenue and Growth Rate (2013-2018)
Table Middle East and Africa Schizophrenia Therapeutics Revenue (Million USD) by Countries (2013-2018)
Table Middle East and Africa Schizophrenia Therapeutics Revenue Market Share by Countries (2013-2018)
Figure Middle East and Africa Schizophrenia Therapeutics Revenue Market Share by Countries (2013-2018)
Figure Middle East and Africa Schizophrenia Therapeutics Revenue Market Share by Countries in 2017
Figure Saudi Arabia Schizophrenia Therapeutics Revenue and Growth Rate (2013-2018)
Figure UAE Schizophrenia Therapeutics Revenue and Growth Rate (2013-2018)
Figure Egypt Schizophrenia Therapeutics Revenue and Growth Rate (2013-2018)
Figure Nigeria Schizophrenia Therapeutics Revenue and Growth Rate (2013-2018)
Figure South Africa Schizophrenia Therapeutics Revenue and Growth Rate (2013-2018)
Table Global Schizophrenia Therapeutics Revenue (Million USD) by Type (2013-2018)
Table Global Schizophrenia Therapeutics Revenue Share by Type (2013-2018)
Figure Global Schizophrenia Therapeutics Revenue Share by Type (2013-2018)
Figure Global Schizophrenia Therapeutics Revenue Share by Type in 2017
Table Global Schizophrenia Therapeutics Revenue Forecast by Type (2018-2023)
Figure Global Schizophrenia Therapeutics Market Share Forecast by Type (2018-2023)
Figure Global First-Generation Antipsychotic Drugs Revenue Growth Rate (2013-2018)
Figure Global Second-Generation Antipsychotic Drugs Revenue Growth Rate (2013-2018)
Figure Global Third-Generation Antipsychotic Drugs Revenue Growth Rate (2013-2018)
Table Global Schizophrenia Therapeutics Revenue by Application (2013-2018)
Table Global Schizophrenia Therapeutics Revenue Share by Application (2013-2018)
Figure Global Schizophrenia Therapeutics Revenue Share by Application (2013-2018)
Figure Global Schizophrenia Therapeutics Revenue Share by Application in 2017
Table Global Schizophrenia Therapeutics Revenue Forecast by Application (2018-2023)
Figure Global Schizophrenia Therapeutics Market Share Forecast by Application (2018-2023)
Figure Global Hospitals Revenue Growth Rate (2013-2018)
Figure Global Clinics Revenue Growth Rate (2013-2018)
Figure Global Other Revenue Growth Rate (2013-2018)
Figure Global Schizophrenia Therapeutics Revenue (Million USD) and Growth Rate Forecast (2018 -2023)
Table Global Schizophrenia Therapeutics Revenue (Million USD) Forecast by Regions (2018-2023)
Figure Global Schizophrenia Therapeutics Revenue Market Share Forecast by Regions (2018-2023)
Figure North America Schizophrenia Therapeutics Revenue Market Forecast (2018-2023)
Figure Europe Schizophrenia Therapeutics Revenue Market Forecast (2018-2023)
Figure Asia-Pacific Schizophrenia Therapeutics Revenue Market Forecast (2018-2023)
Figure South America Schizophrenia Therapeutics Revenue Market Forecast (2018-2023)
Figure Middle East and Africa Schizophrenia Therapeutics Revenue Market Forecast (2018-2023)
